Clinical Trial

Left Bundle Branch Area Pacing (LBBAP) PMCF Study

Name: Left Bundle Branch Area Pacing (LBBAP) PMCF Study — clinical trial record (NCT07217392)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LBBAP PMCF

Recruiting

View on ClinicalTrials.gov →

Summary

The objective of this study is to evaluate the safety and effectiveness of LBBA pacing/sensing in patients implanted with the Tendril STS 2088TC or UltiPace LPA1231 lead through 6 months post-implant.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-10-14.

Trial Details

NCT Number	NCT07217392
Lead Sponsor	Abbott Medical Devices
Conditions	Bradycardia, Right Ventricular Pacing, Heart Failure, Atrial Fibrillation (AF), Cardiac Disease, Left Bundle Branch Area Pacing, Conduction System Pacing
Enrollment	200 participants
Start Date	2025-07-24
Primary Completion	2027-04-30 (estimated)
Study Completion	2027-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-24